Radiopharmaceuticals: molecular imaging using positron emission tomography.

Area of Science:

• Nuclear medicine
• Radiochemistry
• Biomedical imaging

Background:

• Molecular imaging enables visualization of biological processes at the molecular level.
• Positron emission tomography (PET) is a sensitive imaging technique.
• Understanding biochemical events is crucial for biomedical research and drug development.

Purpose of the Study:

• To describe the application of short-lived radionuclides in molecular imaging using PET.
• To highlight the use of molecular probes for quantifying biochemical events.
• To discuss the role of PET in drug development and understanding complex biological processes.

Main Methods:

• Utilizing molecules labeled with short-lived emitting radionuclides.
• Applying positron emission tomography (PET) for molecular imaging.
• Employing position-specific labeling of tracer molecules.

Main Results:

• PET allows visualization and quantitative assessment of specific biochemical events (e.g., synaptic transmission, enzyme activity, receptor binding).
• The sensitivity of PET enables validation of relationships between molecular events and biological functions.
• Position-specific labeling offers critical insights in specific applications.

Conclusions:

• Molecular imaging with PET is a powerful tool for biomedical research.
• PET facilitates early proof-of-concept studies in drug development.
• Understanding complex biological processes is enhanced through PET and position-specific molecular probes.